Synthetic melanin nanoparticles and uses thereof
US-2020113934-A1 · Apr 16, 2020 · US
US11072681B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11072681-B2 |
| Application number | US-201515329526-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 28, 2015 |
| Priority date | Jul 28, 2014 |
| Publication date | Jul 27, 2021 |
| Grant date | Jul 27, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are compositions and methods of making high density nucleic acid polymers.
Opening claim text (preview).
What is claimed is: 1. A graft polymer comprising a linear backbone covalently bound to a plurality of oligonucleotide branches; wherein the graft polymer has the formula: R 1 —[M(O)] n —R 2 wherein, n is an integer from 2 to 1000; M is a polymerized ROMP polymerizable monomer; O is an oligonucleotide covalently attached directly to M or to M through a covalent linker; and R 1 and R 2 are terminal polymer moieties, wherein 100% of the polymerized ROMP polymerizable monomers are each individually attached directly to the oligonucleotide or to the oligonucleotide through a covalent linker, and wherein the polymerizable monomer is N-substituted-5-norbornene-2,3-dicarboximide, wherein the substitution comprises the oligonucleotide. 2. The graft polymer of claim 1 , wherein said oligonucleotide comprises at least 3 nucleobases and at least 2 different nucleobases. 3. The graft polymer of claim 1 comprising at least 3 oligonucleotide branches. 4. The graft polymer of claim 1 , wherein R 1 and R 2 each independently comprise a substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl. 5. The graft polymer of claim 1 , wherein M(O) is wherein, L 1 is independently a bond, —O—, —NH—, —COO—, —S—, —SO 2 —, —SO 3 —, —SO 4 —, —SO 2 NH—, —NHC(O)—, —C(O)NH—, —NHC(O)O—, substituted or unsubstituted alkylene, substituted or unsubstituted heteroalkylene, substituted or unsubstituted cycloalkylene, substituted or unsubstituted heterocycloalkylene, substituted or unsubstituted arylene, or substituted or unsubstituted heteroarylene; and R 4 is the oligonucleotide. 6. The graft polymer of claim 5 , wherein R 1 and R 2 each independently comprise a substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl. 7. The graft polymer of claim 6 , wherein the oligonucleotide comprises at least 3 nucleobases and at least 2 different nucleobases.
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title
Side-chains containing nitrogen · CPC title
Ring opening metathesis polymerisation [ROMP] · CPC title
Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes · CPC title
derived from norbornene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.